Stock research
RPRX — ROYALTY PHARMA PLC
RPRX is reported by 11 tracked managers with $1.0B in visible reported value. This page connects ownership breadth, filing activity, and price context.
Stock research evidence
The latest visible filing snapshot is 2026 Q2. Values come from reported manager holdings; prices and 52-week context come from the latest available market quote.
- Tracked holders
- 11
- Reported value
- $1.0B
- Ownership breadth
- Not available
- Current price
- $59
Top reported managers
These managers have the largest visible reported positions in RPRX. Portfolio weight is measured within each manager's latest visible filing.
- Cliff Asness0.1% of reported portfolio · $241.4M · Filed Aug 14, 2026
- Samantha McLemore6.7% of reported portfolio · $201.8M · Reduce · Filed Aug 13, 2026
- John Overdeck / David Siegel0.1% of reported portfolio · $163.7M · Add · Filed Aug 14, 2026
- Pat Dorsey8.8% of reported portfolio · $137.7M · Add · Filed Aug 14, 2026
- Jim Simons0.1% of reported portfolio · $108.5M · Add · Filed Aug 13, 2026
Continue the research
Review the manager roster, compare this company with the most widely held stocks, or browse transparent screens built from the same filing-backed data.